Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Total Current Liabilities 2011-2025 | ZTS

Zoetis total current liabilities from 2011 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Zoetis total current liabilities for the quarter ending March 31, 2025 were $3.385B, a 77.32% increase year-over-year.
  • Zoetis total current liabilities for 2024 were $3.412B, a 80.62% increase from 2023.
  • Zoetis total current liabilities for 2023 were $1.889B, a 40.35% decline from 2022.
  • Zoetis total current liabilities for 2022 were $3.167B, a 76.24% increase from 2021.
  
Zoetis Annual Total Current Liabilities
(Millions of US $)
2024 $3,412
2023 $1,889
2022 $3,167
2021 $1,797
2020 $2,170
2019 $1,806
2018 $1,223
2017 $1,094
2016 $1,117
2015 $1,781
2014 $1,086
2013 $1,415
2012 $1,123
2011 $843
2010 $0
Zoetis Quarterly Total Current Liabilities
(Millions of US $)
2025-03-31 $3,385
2024-12-31 $3,412
2024-09-30 $1,702
2024-06-30 $1,797
2024-03-31 $1,909
2023-12-31 $1,889
2023-09-30 $1,608
2023-06-30 $1,769
2023-03-31 $1,915
2022-12-31 $3,167
2022-09-30 $2,880
2022-06-30 $3,051
2022-03-31 $3,034
2021-12-31 $1,797
2021-09-30 $1,471
2021-06-30 $2,091
2021-03-31 $2,066
2020-12-31 $2,170
2020-09-30 $2,400
2020-06-30 $1,811
2020-03-31 $1,721
2019-12-31 $1,806
2019-09-30 $1,052
2019-06-30 $1,075
2019-03-31 $1,082
2018-12-31 $1,223
2018-09-30 $1,003
2018-06-30 $967
2018-03-31 $1,000
2017-12-31 $1,094
2017-09-30 $1,746
2017-06-30 $1,784
2017-03-31 $1,730
2016-12-31 $1,117
2016-09-30 $1,039
2016-06-30 $1,039
2016-03-31 $1,163
2015-12-31 $1,781
2015-09-30 $1,658
2015-06-30 $1,572
2015-03-31 $1,370
2014-12-31 $1,086
2014-09-30 $998
2014-06-30 $1,061
2014-03-31 $1,127
2013-12-31 $1,415
2013-09-30 $1,308
2013-06-30 $1,321
2013-03-31 $1,287
2012-12-31 $1,123
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $843
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $71.977B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.131B 31.18
Takeda Pharmaceutical (TAK) Japan $47.379B 9.42
Daiichi Sankyo, - (DSNKY) Japan $45.180B 23.16
BeOne Medicines - (ONC) Cayman Islands $27.838B 0.00
Sandoz Group AG (SDZNY) Switzerland $22.876B 0.00
Merck (MKKGY) Germany $16.572B 12.14
Summit Therapeutics (SMMT) United States $14.742B 0.00
Shionogi (SGIOY) Japan $14.496B 14.52
United Therapeutics (UTHR) United States $12.940B 11.45
Neurocrine Biosciences (NBIX) United States $12.359B 42.33
Orion OYJ (ORINY) Finland $10.283B 27.81
IPSEN (IPSEY) France $10.093B 0.00
Corcept Therapeutics (CORT) United States $7.619B 61.94
Stevanato Group S.p.A (STVN) Italy $7.299B 44.63
Madrigal Pharmaceuticals (MDGL) United States $6.208B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.754B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.911B 0.00
Hypermarcas (HYPMY) Brazil $3.177B 20.90
Crinetics Pharmaceuticals (CRNX) United States $2.888B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.832B 9.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.476B 13.39
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.076B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.967B 0.00
Indivior (INDV) United States $1.899B 8.05
Centessa Pharmaceuticals (CNTA) United Kingdom $1.683B 0.00
ARS Pharmaceuticals (SPRY) United States $1.456B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.322B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.234B 0.00
Harrow (HROW) United States $1.116B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.069B 21.38
Verve Therapeutics (VERV) United States $1.014B 0.00
Collegium Pharmaceutical (COLL) United States $0.946B 5.10
Akebia Therapeutics (AKBA) United States $0.919B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Ardelyx (ARDX) United States $0.849B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.604B 0.00
Xencor (XNCR) United States $0.591B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.33
Altimmune (ALT) United States $0.559B 0.00
Theravance Biopharma (TBPH) United States $0.530B 0.00
Relay Therapeutics (RLAY) United States $0.525B 0.00
Bioventus (BVS) United States $0.522B 13.23
AleAnna (ANNA) United States $0.491B 0.00
Zevra Therapeutics (ZVRA) United States $0.482B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Tourmaline Bio (TRML) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.450B 9.40
Oruka Therapeutics (ORKA) United States $0.448B 0.00
Organogenesis (ORGO) United States $0.397B 0.00
Savara (SVRA) United States $0.353B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.342B 9.26
Liminatus Pharma (LIMN) United States $0.333B 0.00
Aquestive Therapeutics (AQST) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.22
Tonix Pharmaceuticals Holding (TNXP) United States $0.257B 0.00
ProKidney (PROK) United States $0.251B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Esperion Therapeutics (ESPR) United States $0.216B 0.00
MediWound (MDWD) Israel $0.214B 0.00
OmniAb (OABI) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.204B 0.00
4D Molecular Therapeutics (FDMT) United States $0.192B 0.00
Aldeyra Therapeutics (ALDX) United States $0.185B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Aclaris Therapeutics (ACRS) United States $0.152B 0.00
Galectin Therapeutics (GALT) United States $0.151B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.151B 0.00
Journey Medical (DERM) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Avita Medical (RCEL) United States $0.138B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Korro Bio (KRRO) United States $0.118B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.111B 18.30
Nektar Therapeutics (NKTR) United States $0.108B 0.00
Achieve Life Sciences (ACHV) Canada $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Wellgistics Health (WGRX) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.087B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Surrozen (SRZN) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Telomir Pharmaceuticals (TELO) United States $0.055B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
Jupiter Neurosciences (JUNS) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
FibroGen (FGEN) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00